(RTTNews) - Transgene announced that its randomized Phase II study to evaluate TG4001 in combination with avelumab versus avelumab alone in patients with recurrent or metastatic HPV16-positive ...

Although the vast majority of physicians using an artificial intelligence (AI) scribe perceived a reduction in documentation time, those with the most actual time savings had higher relative baseline ...

Introduction Globally, half of all 6.2 million deaths in children are caused by acute illnesses which can be prevented if ...